The new versatile E-Flex Platform will allow vehicle manufacturers a faster entry into the electric vehicle market at a substantially reduced development cost.
Karma, the Southern California-based creator of luxury electric cars and high-tech incubator, unveiled the Karma E-Flex Platform, a highly versatile chassis that will offer new electric vehicle mobility solutions ranging from autonomously-driven utility vans, to ‘every-day’ driver vehicles, to high-performance supercars.
Karma recognized a high demand within the electric vehicle market to develop a new electrified platform with increased versatility. Prior to Karma’s E-Flex Platform, the cost required to develop, test, certify and build a new EREV or BEV platform has been prohibitive, requiring as much as a billion-dollar investment for manufacturers.
The company said the first showcase of the highly-flexible platform currently supports the company’s 2020 Revero GT extended-range electric vehicle (EREV). As part of the electric automotive project, additional EREV platform offerings, platforms for battery-electric-only vehicles (BEVs), and ‘proof-of-concept’ vehicles will be showcased in coming weeks.
Overall, the goal of the project will demonstrate Karma’s growing capabilities and highlight the E-Flex Platform’s core high-tech applications including autonomy, software and hardware, artificial intelligence and advanced transportation solutions.
“We created a physical product that can be formatted into five different products, what others have called a one-dimensional skateboard, but what we call our E-Flex Platform, a multi-use solution. We can deliver a wide range of configurations dependent on the builder’s priority,” said Karma Automotive COO, Kevin Pavlov.
“Taken together, our emerging technology, manufacturing, design and other services leverage our expertise – and the capabilities of our partners – to offer truly innovative solutions. We look forward to showing more of Karma’s unique platform solutions and technology in coming months,” said Karma CEO, Dr. Lance Zhou.